Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: B
Recalled October 3, 2018 · FDA recall D-1217-2018 · Boehringer Ingelheim Pharmaceuticals
Hazard
Cross Contamination With Other Products: · FDA Class II
Units
998 180-count bottles
Sold at
Nationwide
Description
Cross Contamination With Other Products:
Product
Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI Pharmaceuticals, Inc. Ridgefield, CT 06877 and Eli Lilly and Company Indianapolis IN 46285 NDC 0597-0175-18
Manufacturer(s)
Boehringer Ingelheim Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →